Editorial: No need for an ''expiry date'' in chronic peritoneal dialysis to prevent encapsulating peritoneal sclerosis

International Urology and Nephrology

Volumn 41, Issue 4, 2009, Pages 903-907

  Garosi, Guido ^a   Oreopoulos, Dimitrios G ^b  

^a UNIVERSITY HOSPITAL OF SIENA   (Italy)

^b UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CALCINEURIN INHIBITOR; CYCLOSPORIN; EVEROLIMUS; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN; TACROLIMUS;

CADAVER DONOR; EDITORIAL; HUMAN; KIDNEY FAILURE; KIDNEY FIBROSIS; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MEDICAL DECISION MAKING; MEDICAL RESEARCH; PERITONEAL DIALYSIS; PERITONEAL DISEASE; PERITONEAL SCLEROSIS; RISK ASSESSMENT; RISK REDUCTION; TREATMENT DURATION; TREATMENT WITHDRAWAL; DECISION MAKING; FEMALE; FOLLOW UP; LONG TERM CARE; MALE; METHODOLOGY; PERITONEAL FIBROSIS; TIME;

DECISION MAKING; FEMALE; FOLLOW-UP STUDIES; HUMANS; LONG-TERM CARE; MALE; PERITONEAL DIALYSIS; PERITONEAL FIBROSIS; RISK ASSESSMENT; TIME FACTORS; WITHHOLDING TREATMENT;

EID: 77954564864     PISSN: 03011623     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11255-009-9661-7     Document Type: Editorial

References (43)

1. Brown MC, Simpson K, Kerssens JJ, Mactier RA (2009) Encapsulating peritoneal sclerosis in the new millennium: a national cohort study. Clin J Am Soc Nephrol 4:1222-1229
2. Kawanishi H, Long-Term Peritoneal Dialysis Study Group (2001) Encapsulating peritoneal sclerosis in Japan: prospective multicenter controlled study. Perit Dial Int 21(S3):S67-S71
3. Kawanishi H, Kawagushi Y, Fukui H, Hara S, Imada A, Kubo H, Kin M, Nakamoto M, Ohira S, Shoji T (2004) Encapsulating peritoneal sclerosis in Japan: a prospective, controlled, multicenter study. Am J Kidney Dis 44: 729-737
4. Rigby RJ, Hawley CM (1998) Sclerosing peritonitis: the experience in Australia. Nephrol Dial Transplant 13: 154-159
5. Lee HY, Kim BS, Choi HY, Park HC, Kang SW, Choi KH, Ha SK, Han DS (2003) Sclerosing encapsulating peritonitis as a complication of long-term continuous ambulatory peritoneal dialysis in Korea. Nephrol (Carlton) 8:S33-S39
6. Nomoto Y, Kawagushi Y, Kubo H, Hirano H, Sakai S, Kurokawa K (1996) Sclerosing encapsulating peritonitis in patients undergoing continuous ambulatory peritoneal dialysis: a report of the Japanese sclerosing encapsulating peritonitis study group. Am J Kidney Dis 20:420-427
7. Summers AM, Clancy MJ, Syed F, Harwood N, Brenchley PE, Augustine T, Riad H, Hutchison AJ, Taylor P, Pearson R, Gokal R (2005) Single-center experience of encapsulating peritoneal sclerosis in patients on peritoneal dialysis for end stage renal failure. Kidney Int 68:2381-2388
8. Fieren MWJA, Betjes MGH, Korte MR, Boer WH (2007) Posttransplant encapsulating peritoneal sclerosis: a worrying new trend? Perit Dial Int 27:619-624
9. Nakayama M, Maruyama Y, Numata M (2005) Encapsulating peritoneal sclerosis is a separate entity: con. Perit Dial Int 5(S3):S107-S109
10. Garosi G, Di Paolo N, Sacchi G, Gaggiotti E (2005) Sclerosing peritonitis: a nosological entity. Perit Dial Int 5(S3):S110-S112
11. Yamamoto M, Nakayama M, Hasegawa T, Miwako N, Yamamoto H, Yokoyami K, Ikeda M, Kato N, Hayakawa H, Takahashi H, Otsuka Y, Kawagushi Y, Hosoya T (2002) High-transport membrane is a risk factor for encapsulating peritoneal sclerosis developing after long-term continuous ambulatory peritoneal dialysis treatment. Adv Perit Dial 18:131-134
12. Honda K, Nitta K, Horita S, Tsukada M, Itabashi M, Nihei H, Takashi A, Oda H (2003) Histologic criteria for diagnosing encapsulating peritoneal sclerosis in continuous ambulatory peritoneal dialysis patients. Adv Perit Dial 19:169-175
13. Sherif AM, Yoshida H, Maruyama Y, Yamamoto H, Yokoyama K, Hosoya T, Kawakami M, Nakayama M (2008) Comparison between the pathology of encapsulating sclerosis and single sclerosis of the peritoneal membrane in chronic peritoneal dialysis. Ther Apher Dial 12:33-41
14. Garosi G, Di Paolo N (2000) Peritoneal sclerosis: one or two nosological entities? Semin Dial 13:297-308
15. Garosi G, Di Paolo N (2001) Inflammation and gross vascular alterations are characteristic histological features of sclerosing peritonitis. Perit Dial Int 21:417-418
16. Garosi G (2009) Different aspects of peritoneal damage: fibrosis and sclerosis. Contrib Nephrol 163:45-53
17. Augustine T, Brown PW, Davies SD, Summers AM, Wilkie ME (2009) Encapsulating peritoneal sclerosis: clinical significance and implications. Nephron Clin Pract 111:c149-c154
18. Summers AM, Brenchley PEC (2006) An international encapsulating peritoneal sclerosis registry and DNA bank: why we need one now. Perit Dial Int 26:559-563
19. Topley N (2006) Encapsulating peritoneal sclerosis: time to act. Perit Dial Int 26:564-565
20. Owtschinnikow PJ (1907) Peritonitis chronica fibrosa incapsulata. Arch Klin Chir 83:623-634
21. Narayanan R, Bhargava BN, Kabra SG, Sangal BC (1989) Idiopathic sclerosing encapsulating peritonitis. Lancet 2:127-129
22. Dehn TC, Lucas MG, Wood RF (1985) Idiopathic sclerosing peritonitis. Postgrad Med J 61:841-842
23. Comings DE, Skubi KD, Van Eyes J, Motulsky AG (1967) Familial multifocal fibrosclerosis. Ann Intern Med 66: 884-892
24. Guest S (2009) Hypothesis: gender and encapsulating sclerosing peritonitis. Perit Dial Int 29:489-491
25. Liakopoulos V, Stefanidis I, Dombros NV (2009) Peritoneal dialysis glossary 2009. Int Urol Nephrol. doi:10.1007/ s11255-009-9619-9
26. Oreopoulos DG, Thodis E, Passadakis P, Vargemezis V (2009) Home dialysis as a first option: a new paradigm. Int Urol Nephrol 41:595-605
27. Russell NKI, Knight SR, Morris PJ (2008) Cyclosporine. In: Morris PJ, Knechtle SJ (eds) Kidney transplantation. Principles and practice, 6th edn. Saunders Elsevier, Philadelphia, pp 234-258
28. Basu A, Shapiro R (2008) Tacrolimus in renal transplantation. In: Morris PJ, Knechtle SJ (eds) Kidney transplantation. Principles and practice, 6th edn. Saunders Elsevier, Philadelphia, pp 259-275
29. Rajani R, Smyth J, Abbs I, Goldsmith JA (2002) Differential effect of sirolimus vs prednisolone in the treatment of sclerosing encapsulating peritonitis. Nephrol Dial Transplant 17:2278-2280
30. Ricciatti AM, Goteri G, D'Arezzo M, Sagripanti S, Bibiano L, Petroselli F, Fabris G, Frascà GM (2008) Peritonite sclerosante trattata con successo con associazione di steroidi, everolimus e tamoxifene. Atti XIV Convegno Gruppo di Studio di Dialisi Peritoneale, Modena, 7-9 febbraio 2008, p 20 (Abs)
31. Lafrance JP, Létourneau I, Ouimet D, Bonnardeaux A, Leblanc M, Mathieu N, Michette V (2008) Successful treatment of encapsulating peritoneal sclerosis with immunosoppressive therapy. Am J Kidney Dis 51:e7-e10
32. Watson CJE, Bradley JA (2008) mTOR inhibitors: sirolimus and everolimus. In: Morris PJ, Knechtle SJ (eds) Kidney transplantation. Principles and practice, 6th edn. Saunders Elsevier, Philadelphia, pp 293-308
33. Kahan BD (2008) Mycophenolate mofetil. In: Morris PJ, Knechtle SJ (eds) Kidney transplantation. Principles and practice, 6th edn. Saunders Elsevier, Philadelphia, pp 277-292
34. Ahmad M, Shah H, Pliakogiannis T, Oreopoulos DG (2007) Prevention of membrane damage in patients on peritoneal dialysis with new peritoneal dialysis solutions. Int Urol Nephrol 39:299-312
35. Oreopoulos D, Thodis E, Paraskevas KI (2008) The promising future of long-term peritoneal dialysis. Int Urol Nephrol 40:405-410
36. Witowsky J, Jörres A (2009) Peritoneal dialysis: a biological membrane with a nonbiological fluid. Contrib Nephrol 163:27-34
37. Ersoy R, Celik A, Yilmaz O, Sarioglu S, Sis B, Akan P, Yenicerioglu Y, Ormen M, Camsari T (2007) The effects of irbesartan and spironolactone in prevention of peritoneal fibrosis in rats. Perit Dial Int 27:424-431
38. Duman S, Sen S, Duman C, Oreopoulos DG (2005) Effect of valsartan versus lisinopril on peritoneal sclerosis in rats. Int J Artif Organs 28:156-163
39. Duman S, Wieczorowska-Tobis K, Styszynski A, Kwiatkowska B, Breborowicz A, Oreopoulos DG (2004) Intraperitoneal enalapril ameliorates morphologic changes induced by hypertonic peritoneal dialysis solutions in rat peritoneum. Adv Perit Dial 20:31-36
40. del Peso G, Bajo MA, Gil F, Aguilera A, Ros S, Costero O, Castro MJ, Selgas R (2003) Clinical experience with tamoxifen in peritoneal fibrosing syndromes. Adv Perit Dial 19:32-35
41. Eltoum MA, Wright S, Atchley J, Mason JC (2006) Four consecutive cases of peritoneal dialysis-related encapsulating peritoneal sclerosis treated successfully with tamoxifen. Perit Dial Int 26:203-206
42. Wong CF (2006) Clinical experience with tamoxifen in encapsulating peritoneal sclerosis. Perit Dial Int 26:183-184
43. Thirunavukarasu T, Saxena R, Anijeet H, Pai P, Wong CF (2007) Encapsulating peritoneal sclerosis presenting with recurrent ascites and tamoxifen: case reports and review of the literature. Ren Fail 29:775-776